12.07.2015 Views

EU Industrial R&D Investment Scoreboards 2011

EU Industrial R&D Investment Scoreboards 2011

EU Industrial R&D Investment Scoreboards 2011

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Figure S2. Growth of R&D investment and net sales in the Scoreboardnominal growth rate15%10%5%0%-5%-10%-15%R&D investmentnet sales2008 2009 2010 2008 2009 2010<strong>EU</strong> (€132 bn)US (€160 bn)country (total R&D investment)Source: The <strong>2011</strong> <strong>EU</strong> <strong>Industrial</strong> R&D <strong>Investment</strong> ScoreboardEuropean Commission, JRC/DG RTD.Two pharmaceutical companies have climbed to the top of the ranking:Roche from Switzerland is in first place followed by Pfizer from the US.Volkswagen in sixth place of the world ranking is again the biggest R&Dinvestor headquartered in the <strong>EU</strong>.As observed in previous <strong>Scoreboards</strong>, pharmaceutical companies continue toincrease their presence in the top places. Three US pharmaceutical companiesshowed especially strong R&D growth in 2010: Merck (47%), Abbott (35.7%)and Pfizer (21.4%). By contrast, the biggest <strong>EU</strong>-company in the sector (Sanofi-Aventis, France) has dropped this year out of the top ten ranks and is now 14 th .Another tendency among the top 50 is high R&D investment growth in ICTcompanies: LG (39.5%), Oracle (38.9%), Google (32.3%) and Samsung(24.9%). However, some automobile companies severely hit by last year’seconomic and financial crisis, present remarkable R&D growth: Daimler(16.5%), General Motors (14.7%) and BMW (13.3%).The pharmaceuticals & biotechnology sector strengthens its position asthe biggest sector in terms of R&D, while the other two top sectors(technology hardware & equipment and automobiles & parts) are nowrecovering from last year's downturn.Pharmaceuticals & biotechnology, technology hardware & equipment andautomobiles & parts are the top three sectors constituting more than half ofworldwide R&D investment. This has hardly changed since the first Scoreboardin 2004.R&D investments of pharmaceuticals &biotechnology companies grew by 6.2%in 2010, a little more than in 2009. Technology hardware & equipment andautomobiles & parts are recovering from the significant reductions observed in2009 (from -6.4% to 3.5% and -11.6% to 0% respectively). Upswings in R&Dinvestments were also observed for most other sectors, except for chemicalsand fixed line telecommunications, as well as improved sales growth comparedto 2009.3The <strong>2011</strong> <strong>EU</strong> <strong>Industrial</strong> R&D <strong>Investment</strong> Scoreboard 3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!